This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: July 12, 2026·Last reviewed: October 15, 2026·Methodology v4.1

Researched By

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

Sermorelin: evidence, legality and safety

Quick answer

FDA status, read October 15, 2026Sermorelin: On no FDA category list; brand product discontinued. Drugs@FDA lists the approved product Geref (sermorelin acetate) as discontinued. FDA’s category pages do not list sermorelin, and we found no FDA statement on whether it may be compounded today. Peptide legal status → What the July vote did and did not change → Sources: FDA Category 2 page · 503A category lists (May 14, 2026) · Drugs@FDA.

Sermorelin is a growth-hormone-releasing hormone analog historically used in diagnostic and pediatric growth contexts. It is now marketed by some telehealth and compounding programs for anti-aging and body-composition uses that are not FDA-approved. Evidence for those marketed uses is limited.

Regulatory statusA GHRH analog with a regulated history; current consumer marketing is often through compounding.

What does the evidence actually show?

What human clinical evidence exists?

Historical regulated use exists in specific indications; evidence for anti-aging/physique marketing is limited.

What do the animal and laboratory studies show?

Preclinical GH-axis data exist. We keep animal and laboratory findings clearly separated from human evidence, because preclinical results routinely fail to translate to people.

What are the known and potential risks?

As with other GH secretagogues, effects on glucose metabolism and tissue growth; verify pharmacy legitimacy for any compounded product.

No consumer dosing for research compoundsThis page does not provide dosing instructions for unapproved compounds, and we do not link to research-chemical sellers. If you are considering peptide therapy, do it through a licensed clinician who can weigh your individual risks.

Is it legal, and where does it come from?

The lawful pathway for any prescription peptide is a licensed clinician and a licensed pharmacy. Products labeled "for research use only" are not lawfully sold for human consumption. See how to verify a peptide provider and research peptides versus prescription therapy.

Is it banned in sport?

Prohibited under anti-doping codes.

Frequently asked questions

Is Sermorelin FDA-approved?

A GHRH analog with a regulated history; current consumer marketing is often through compounding.

Is there human evidence for Sermorelin?

Historical regulated use exists in specific indications; evidence for anti-aging/physique marketing is limited.

Is Sermorelin legal to buy?

Many peptides in this category are sold as 'research chemicals,' which is not a lawful pathway for human use. Legitimacy depends on approval status and whether a licensed clinician and pharmacy are involved. We do not link to research-chemical sellers.

Is Sermorelin banned in sport?

Prohibited under anti-doping codes.

Sources

U.S. Food and Drug Administration — enforcement actions and warnings on unapproved peptide products.
World Anti-Doping Agency (WADA) Prohibited List — current edition.
Peer-reviewed preclinical and (where available) clinical literature, graded for evidence quality.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.